LifeStance Health Group, Inc. (LFST) Q3 2023 Earnings Call Transcript

LifeStance Health Group, Inc. (NASDAQ:LFST) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET

Company Participants

Monica Prokocki – Vice President, Investor Relations

Ken Burdick – Chief Executive Officer

Dave Bourdon – Chief Financial Officer

Danish Qureshi – Chief Operating Officer

Conference Call Participants

Craig Hettenbach – Morgan Stanley

Lisa Gill – JP Morgan

Jack Senft – William Blair

Kevin Caliendo – UBS

Jamie Perse – Goldman Sach

Brian Tanquilut – Jefferies

Gary Taylor – TD Cowen


Ladies and gentlemen, Thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the LifeStance Health Third Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions].

I would now like to turn the conference over to Monica Prokocki, Vice President of Investor Relations. Please go ahead.

Monica Prokocki

Good morning, everyone and welcome to LifeStance Health’s third quarter 2023 earnings conference call. I am Monica Prokocki, Vice President of Investor Relations. Joining me today are Ken Burdick, Chief Executive Officer, Dave Bourdon, Chief Financial Officer; and Danish Qureshi, Chief Operating Officer.

We issued the earnings release and presentation before the market opened this morning. Both are available on the Investor Relations section of our website, In addition, a replay of this conference call will be available following the call.

Before turning the call over to management for their prepared remarks, please direct your attention to the disclaimers about forward-looking statements included in the earnings press release and SEC filings. Today’s remarks contain forward-looking statements, including statements about our financial performance outlook, business model, and strategy. Those statements involve risks, uncertainties, and other factors, as noted in our periodic filings with the SEC, that

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *